Anti-CD15 monoclonal antibody

Pre-made anti-CD15 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CD15/FUT4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0027-Ab-1/ GM-Tg-hg-IP0027-Ab-2Anti-Human CD15/FUT4 monoclonal antibodyHuman
GM-Tg-rg-IP0027-Ab-1/ GM-Tg-rg-IP0027-Ab-2Anti-Rat CD15/FUT4 monoclonal antibodyRat
GM-Tg-mg-IP0027-Ab-1/ GM-Tg-mg-IP0027-Ab-2Anti-Mouse CD15/FUT4 monoclonal antibodyMouse
GM-Tg-cynog-IP0027-Ab-1/ GM-Tg-cynog-IP0027-Ab-2Anti-Cynomolgus/ Rhesus macaque CD15/FUT4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0027-Ab-1/ GM-Tg-felg-IP0027-Ab-2Anti-Feline CD15/FUT4 monoclonal antibodyFeline
GM-Tg-cang-IP0027-Ab-1/ GM-Tg-cang-IP0027-Ab-2Anti-Canine CD15/FUT4 monoclonal antibodyCanine
GM-Tg-bovg-IP0027-Ab-1/ GM-Tg-bovg-IP0027-Ab-2Anti-Bovine CD15/FUT4 monoclonal antibodyBovine
GM-Tg-equg-IP0027-Ab-1/ GM-Tg-equg-IP0027-Ab-2Anti-Equine CD15/FUT4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0027-Ab-1/ GM-Tg-hg-IP0027-Ab-2; GM-Tg-rg-IP0027-Ab-1/ GM-Tg-rg-IP0027-Ab-2;
GM-Tg-mg-IP0027-Ab-1/ GM-Tg-mg-IP0027-Ab-2; GM-Tg-cynog-IP0027-Ab-1/ GM-Tg-cynog-IP0027-Ab-2;
GM-Tg-felg-IP0027-Ab-1/ GM-Tg-felg-IP0027-Ab-2; GM-Tg-cang-IP0027-Ab-1/ GM-Tg-cang-IP0027-Ab-2;
GM-Tg-bovg-IP0027-Ab-1/ GM-Tg-bovg-IP0027-Ab-2; GM-Tg-equg-IP0027-Ab-1/ GM-Tg-equg-IP0027-Ab-2
Products NameAnti-CD15/FUT4 monoclonal antibody
Formatmab
Target NameCD15
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CD15 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-INN-1011Pre-Made Technetium (99Mtc) Fanolesomab Biosimilar, Radiolabelled Antibody, Anti-Cd15 Antibody: Anti-ELFT/FCT3A/FUC-TIV/FUTIV/LeX/SSEA-1 therapeutic antibody
    Target AntigenGM-Tg-g-IP0027-Ag-1Recombinant multi-species FUT4/ CD15/ ELFT protein
    ORF Viral VectorpGMLPm005170mouse Fut4 Lentivirus plasmid
    ORF Viral VectorvGMLPm005170mouse Fut4 Lentivirus particle


    Target information

    Target IDGM-IP0027
    Target NameCD15
    Gene ID2526,14345,60670,698078,100682680,101086174,282854,100067105
    Gene Symbol and SynonymsCD15,ELFT,FAL,FCT3A,FUC-TIV,Fuct,FucT-IV,FUT4,FUTIV,LeX,SSEA-1,Ssea1
    Uniprot AccessionP22083,Q62994,Q8HZR3
    Uniprot Entry NameFUT4_HUMAN,FUT4_RAT,FUT4_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target, INN Index
    DiseaseCancer
    Gene EnsemblENSG00000196371
    Target ClassificationTumor-associated antigen (TAA)

    The target: CD15, gene name: FUT4, also named as CD15, ELFT, FCT3A, FUC-TIV, FUTIV, LeX, SSEA-1. The product of this gene transfers fucose to N-acetyllactosamine polysaccharides to generate fucosylated carbohydrate structures. It catalyzes the synthesis of the non-sialylated antigen, Lewis x (CD15). [provided by RefSeq, Jan 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.